Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3859)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 26, 2024 (publication date) through Mar 22, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Shah S, Nawaz HS, Qazi MS, Jain H, Lucke-Wold B. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure. World J Cardiol 2024; 16(11): 619-625 [PMID: 39600993 DOI: 10.4330/wjc.v16.i11.619] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Shah S, Nawaz HS, Qazi MS, Jain H, Lucke-Wold B. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure. World J Cardiol 2024; 16(11): 619-625 [PMID: 39600993 DOI: 10.4330/wjc.v16.i11.619] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i11/619.htm |
| Number | Citing Articles |
| 1 |
Jie Zhang, Chao Nai, Jue Wang, Liping Su, Xiaona Ning, Chenjun Guo. USP33 Facilitates Retinoblastoma Growth by Deubiquitinating and Stabilizing EPHB2 Protein. Applied Biochemistry and Biotechnology 2025; 197(10): 6834 doi: 10.1007/s12010-025-05357-3
|
| 2 |
Huangxi Fu, Feng Jiang, Anqi Xu, Taicheng Zhou, Ning Liu, Xueqin Chen, Zizheng Gao, Wentong Wu, Hao Yan, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo, Zhifei Xu. MEK inhibitor induces cardiac complications by preventing ZMYND8-mediated ubiquitination and proteasomal degradation of HMGB1. Biochemical Pharmacology 2026; 245: 117660 doi: 10.1016/j.bcp.2025.117660
|
| 3 |
Yinjing Luo, Yang Zhou, Yuheng He, Tao Liu, Feilong Li, Chao Song, Jingwen Chen, Zongchao Liu, Li Peng. Molecular mechanisms and treatment strategies for bone defects: From hypoxia–inflammation–ferritinophagy vicious cycle to intelligent biomaterial application. Tissue and Cell 2026; 101: 103480 doi: 10.1016/j.tice.2026.103480
|
| 4 |
Swathi NL, Zaid Shakhatreh, Abeer Tahir, Jasmeet Singh, Samia Sulaiman, Athul H, Abhilash Sadhankar, Palak Patel, Rahul Patel, Abdulqadir J Nashwan. Epigenetic Mechanisms in the Transfer of Metabolic Disorders: A Comprehensive Review. Cureus 2025; doi: 10.7759/cureus.80418
|